AvCommittee on the Public Health Effectiveness of the FDA 510(k) Clearance Process,Board on Population Health and Public Health Practice
658 kr
Läs direkt i Bokus Reader – eller ladda ned till din enhet
The Food and Drug Administration (FDA) is responsible for assuring that medical devices are safe and effective before they go on the market. As part of its assessment of FDA''s premarket clearance process for medical devices, the IOM held a workshop June 14-15 to discuss how to best balance patient safety and technological innovation. This document summarizes the workshop.
Institute of Medicine, Board on Population Health and Public Health Practice, Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, Theresa Wizemann
Häftad, 2010
702 kr
Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, Board on Population Health and Public Health Practice, Institute of Medicine
866 kr
Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, Board on Population Health and Public Health Practice, Institute of Medicine
952 kr
Institute of Medicine, Board on Population Health and Public Health Practice, Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, Theresa Wizemann
Häftad, 2011
408 kr
Institute of Medicine, Board on Population Health and Public Health Practice, Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process
Häftad, 2011
542 kr
Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, Board on Population Health and Public Health Practice, Institute of Medicine, Theresa Wizemann
459 kr
Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, Board on Population Health and Public Health Practice, Institute of Medicine, Theresa Wizemann
598 kr
Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, Board on Population Health and Public Health Practice, Institute of Medicine, Theresa Wizemann
624 kr
Institute of Medicine, Board on Population Health and Public Health Practice, Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, Theresa Wizemann
Häftad, 2011
408 kr
Institute of Medicine, Board on Population Health and Public Health Practice, Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, Theresa Wizemann
Häftad, 2010
702 kr
Institute of Medicine, Board on Population Health and Public Health Practice, Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process
Häftad, 2011
542 kr
Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, Board on Population Health and Public Health Practice, Institute of Medicine
866 kr
Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, Board on Population Health and Public Health Practice, Institute of Medicine
952 kr
Roundtable on Population Health Improvement, Board on Population Health and Public Health Practice, Institute of Medicine, Theresa Wizemann, Darla Thompson
675 kr
Roundtable on Population Health Improvement, Board on Population Health and Public Health Practice, Health and Medicine Division, and Medicine National Academies of Sciences, Engineering, Theresa Wizemann
572 kr
